Alkyne-containing SARS-CoV-2 main protease inhibitors
Novel small-molecules using alkyne groups to inhibit the SARS-CoV-2 main protease.
Home>Pharma/Biopharma
Gene therapy for retinitis pigmentosa due to mutations in the rhodopsin gene
Gene therapy for retinitis pigmentosa due to mutations in the rhodopsin gene
Cross-strain HIV therapeutic vaccine for all geographical regions
Chimeric immunogenic polypeptides, created using the HIVconsv method, are now in clinical trials, offering strong and broad protection against HIV.
Novel antibody-peptide conjugate for combatting Neisseria gonorrhoea resistance
Novel antibody-peptide conjugate for combatting Neisseria gonorrhoea resistance
New RH5-based malaria prophylaxis with stronger infection inhibition
New malaria vaccine designed with stronger infection inhibition
Vaccine delivery technology for greater compliance and coverage, and cost effective vaccination campaigns
Microcapsules for single injection vaccination
A prognostic signature to predict outcome in ovarian cancer patients
A method to accurately predict the prognosis of ovarian cancer by identifying a gene signature associated with the "EMT-high" subtype.
Increasing the potential of the next generation therapeutic oligonucleotides
Next generation therapeutic oligonucleotides.
Virtual native enhancement –a gadolinium-free, needle-free method for cardiac imaging
An AI method that monitors the need for gadolinium-based contrast agents whilst creating images of the heart in high quality.
Practical model-based approach for robust quality assurance of quantitative MRI acquisition methods
A model-based method for validating quantitative methods of cardiovascular MRI
© Oxford University Innovation